Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Crystalline form of N-[[4-fluoro-2-(5-methyl-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-C][1,4]-oxazine-2-carboxamide, sodium salt monohydrate

US Patent 7968541 · Granted Jun 28, 2011

Estimated economic value: $44,563,000

Assignee

Inventors

View full patent text on Google Patents →